HIF1A and gastric cancer: Clinical studies in human GC tissues confirm this interplay: HIF-1α and Adora2b are co-expressed in 68% of primary GC samples, with co-expression correlating with advanced TNM stage (p<0.01) and lymph node metastasis (p<0.05) (53).